Massachusetts Financial Services CO Bristol Myers Squibb CO Transaction History

Massachusetts Financial Services CO

$314 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $946,730 - $1.05 Million	-14,860 Reduced 80.87%	3,515 $224,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $104,544 - $118,577	1,591 Added 9.48%	18,375 $1.27 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $867,025 - $1.03 Million	12,661 Added 307.08%	16,784 $1.21 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $39 - $23,436	-305 Reduced 6.89%	4,123 $293,000
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $28,467 - $31,352	392 Added 9.71%	4,428 $341,000
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $2.37 Million - $2.84 Million	-38,527 Reduced 90.52%	4,036 $295,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $21,612 - $25,195	403 Added 0.96%	42,563 $2.65 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $2.11 Million - $2.47 Million	35,583 Added 541.02%	42,160 $2.5 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $451,200 - $491,356	-7,288 Reduced 52.56%	6,577 $439,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $822,749 - $925,350	13,865 New	13,865 $875,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $23.7 Million - $26.8 Million	-409,953 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $11.1 Million - $12.3 Million	-192,689 Reduced 31.97%	409,953 $24.7 Million
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $14.3 Million - $16.7 Million	-260,199 Reduced 30.16%	602,642 $35.4 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $29.7 Million - $43.1 Million	-639,046 Reduced 42.55%	862,841 $48.1 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $4.57 Million - $5.96 Million	92,854 Added 6.59%	1,501,887 $96.4 Million
Q3 2019 Nov 05, 2019	SELL	$42.77 - $50.71 $39.5 Million - $46.9 Million	-924,451 Reduced 39.62%	1,409,033 $71.5 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $119 Million - $131 Million	-2,658,488 Reduced 53.26%	2,333,484 $106 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $218 Million - $260 Million	-4,828,062 Reduced 49.17%	4,991,972 $238 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $17.5 Million - $22.8 Million	359,886 Added 3.8%	9,820,034 $510 Million
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $160 Million - $181 Million	2,903,920 Added 44.29%	9,460,148 $587 Million
Q2 2018 Jul 30, 2018	SELL	$50.53 - $62.98 $6.19 Million - $7.71 Million	-122,405 Reduced 1.83%	6,556,228 $363 Million
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $28.1 Million - $32.3 Million	468,740 Added 7.55%	6,678,633 $422 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $64.8 Million - $70.7 Million	1,081,642 Added 21.09%	6,209,893 $381 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $148 Million - $171 Million	2,682,106 Added 109.65%	5,128,251 $327 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,446,145	2,446,145 $136 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account